SVAS BIOSANA SPA (SVS.MI) Stock Fundamental Analysis

BIT:SVS • IT0005469264

8.84 EUR
+0.32 (+3.76%)
Last: Feb 16, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership
Fundamental Rating

6

Overall SVS gets a fundamental rating of 6 out of 10. We evaluated SVS against 67 industry peers in the Health Care Equipment & Supplies industry. SVS has an average financial health and profitability rating. SVS has both an excellent growth and valuation score. This means it is growing and it is still cheap. This is a rare combination!


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

  • SVS had positive earnings in the past year.
  • SVS had a negative operating cash flow in the past year.
  • SVS had positive earnings in each of the past 5 years.
  • SVS had a positive operating cash flow in each of the past 5 years.
SVS.MI Yearly Net Income VS EBIT VS OCF VS FCFSVS.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 2M -2M 4M 6M 8M 10M

1.2 Ratios

  • SVS has a Return On Assets of 3.75%. This is comparable to the rest of the industry: SVS outperforms 49.25% of its industry peers.
  • Looking at the Return On Equity, with a value of 10.43%, SVS is in the better half of the industry, outperforming 68.66% of the companies in the same industry.
  • SVS's Return On Invested Capital of 8.04% is fine compared to the rest of the industry. SVS outperforms 65.67% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for SVS is below the industry average of 9.66%.
  • The last Return On Invested Capital (8.04%) for SVS is above the 3 year average (6.63%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 3.75%
ROE 10.43%
ROIC 8.04%
ROA(3y)3.03%
ROA(5y)2.75%
ROE(3y)8.2%
ROE(5y)7.97%
ROIC(3y)6.63%
ROIC(5y)6.34%
SVS.MI Yearly ROA, ROE, ROICSVS.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 2 4 6 8 10

1.3 Margins

  • SVS has a Profit Margin (5.09%) which is comparable to the rest of the industry.
  • SVS's Profit Margin has improved in the last couple of years.
  • SVS's Operating Margin of 8.71% is in line compared to the rest of the industry. SVS outperforms 44.78% of its industry peers.
  • In the last couple of years the Operating Margin of SVS has grown nicely.
  • SVS's Gross Margin of 26.17% is on the low side compared to the rest of the industry. SVS is outperformed by 88.06% of its industry peers.
  • In the last couple of years the Gross Margin of SVS has declined.
Industry RankSector Rank
OM 8.71%
PM (TTM) 5.09%
GM 26.17%
OM growth 3Y3.27%
OM growth 5Y3.94%
PM growth 3Y7.81%
PM growth 5Y7.66%
GM growth 3Y-3.21%
GM growth 5Y-2.88%
SVS.MI Yearly Profit, Operating, Gross MarginsSVS.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 10 20 30

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so SVS is still creating some value.
  • SVS has less shares outstanding than it did 1 year ago.
  • SVS has less shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, SVS has an improved debt to assets ratio.
SVS.MI Yearly Shares OutstandingSVS.MI Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M 4M 5M
SVS.MI Yearly Total Debt VS Total AssetsSVS.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

2.2 Solvency

  • An Altman-Z score of 1.82 indicates that SVS is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • SVS's Altman-Z score of 1.82 is on the low side compared to the rest of the industry. SVS is outperformed by 64.18% of its industry peers.
  • SVS has a Debt/Equity ratio of 0.62. This is a neutral value indicating SVS is somewhat dependend on debt financing.
  • SVS's Debt to Equity ratio of 0.62 is on the low side compared to the rest of the industry. SVS is outperformed by 67.16% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.62
Debt/FCF N/A
Altman-Z 1.82
ROIC/WACC1.13
WACC7.12%
SVS.MI Yearly LT Debt VS Equity VS FCFSVS.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M

2.3 Liquidity

  • SVS has a Current Ratio of 1.82. This is a normal value and indicates that SVS is financially healthy and should not expect problems in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 1.82, SVS is in line with its industry, outperforming 58.21% of the companies in the same industry.
  • SVS has a Quick Ratio of 1.34. This is a normal value and indicates that SVS is financially healthy and should not expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 1.34, SVS is in the better half of the industry, outperforming 64.18% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.82
Quick Ratio 1.34
SVS.MI Yearly Current Assets VS Current LiabilitesSVS.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

7

3. Growth

3.1 Past

  • SVS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 24.41%, which is quite impressive.
  • The Earnings Per Share has been growing by 19.97% on average over the past years. This is quite good.
  • Looking at the last year, SVS shows a quite strong growth in Revenue. The Revenue has grown by 9.07% in the last year.
  • SVS shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 10.34% yearly.
EPS 1Y (TTM)24.41%
EPS 3Y23.97%
EPS 5Y19.97%
EPS Q2Q%34.09%
Revenue 1Y (TTM)9.07%
Revenue growth 3Y14.06%
Revenue growth 5Y10.34%
Sales Q2Q%21.03%

3.2 Future

  • Based on estimates for the next years, SVS will show a quite strong growth in Earnings Per Share. The EPS will grow by 14.83% on average per year.
  • The Revenue is expected to grow by 9.07% on average over the next years. This is quite good.
EPS Next Y33.33%
EPS Next 2Y17.92%
EPS Next 3Y14.83%
EPS Next 5YN/A
Revenue Next Year19.23%
Revenue Next 2Y11.86%
Revenue Next 3Y9.07%
Revenue Next 5YN/A

3.3 Evolution

  • Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
SVS.MI Yearly Revenue VS EstimatesSVS.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 50M 100M 150M
SVS.MI Yearly EPS VS EstimatesSVS.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0.5 1 1.5

More info and screens

Find the best growth stocksShow best growing peers

7

4. Valuation

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 6.96, the valuation of SVS can be described as very cheap.
  • 100.00% of the companies in the same industry are more expensive than SVS, based on the Price/Earnings ratio.
  • When comparing the Price/Earnings ratio of SVS to the average of the S&P500 Index (26.99), we can say SVS is valued rather cheaply.
  • Based on the Price/Forward Earnings ratio of 5.99, the valuation of SVS can be described as very cheap.
  • Based on the Price/Forward Earnings ratio, SVS is valued cheaper than 95.52% of the companies in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 28.06. SVS is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 6.96
Fwd PE 5.99
SVS.MI Price Earnings VS Forward Price EarningsSVS.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • 94.03% of the companies in the same industry are more expensive than SVS, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 4.76
SVS.MI Per share dataSVS.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20

4.3 Compensation for Growth

  • SVS's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as SVS's earnings are expected to grow with 14.83% in the coming years.
PEG (NY)0.21
PEG (5Y)0.35
EPS Next 2Y17.92%
EPS Next 3Y14.83%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

6

5. Dividend

5.1 Amount

  • SVS has a Yearly Dividend Yield of 2.80%. Purely for dividend investing, there may be better candidates out there.
  • Compared to an average industry Dividend Yield of 1.15, SVS pays a better dividend. On top of this SVS pays more dividend than 91.04% of the companies listed in the same industry.
  • SVS's Dividend Yield is rather good when compared to the S&P500 average which is at 1.81.
Industry RankSector Rank
Dividend Yield 2.8%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

  • 19.64% of the earnings are spent on dividend by SVS. This is a low number and sustainable payout ratio.
DP19.64%
EPS Next 2Y17.92%
EPS Next 3Y14.83%
SVS.MI Yearly Income VS Free CF VS DividendSVS.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2018 2019 2020 2021 2022 2023 2024 0 2M -2M 4M
SVS.MI Dividend Payout.SVS.MI Dividend Payout, showing the Payout Ratio.SVS.MI Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

SVAS BIOSANA SPA

BIT:SVS (2/16/2026, 7:00:00 PM)

8.84

+0.32 (+3.76%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)N/A
Earnings (Next)N/A
Inst Owners5.58%
Inst Owner ChangeN/A
Ins Owners64.79%
Ins Owner ChangeN/A
Market Cap49.50M
Revenue(TTM)132.55M
Net Income(TTM)6.74M
Analysts80
Price Target17.44 (97.29%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.8%
Yearly Dividend0.3
Dividend Growth(5Y)N/A
DP19.64%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)15.93%
PT rev (3m)15.93%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 6.96
Fwd PE 5.99
P/S 0.37
P/FCF N/A
P/OCF N/A
P/B 0.77
P/tB 1.06
EV/EBITDA 4.76
EPS(TTM)1.27
EY14.37%
EPS(NY)1.47
Fwd EY16.68%
FCF(TTM)-1.21
FCFYN/A
OCF(TTM)-0.1
OCFYN/A
SpS23.67
BVpS11.54
TBVpS8.36
PEG (NY)0.21
PEG (5Y)0.35
Graham Number18.16
Profitability
Industry RankSector Rank
ROA 3.75%
ROE 10.43%
ROCE 10.81%
ROIC 8.04%
ROICexc 10.91%
ROICexgc 14.1%
OM 8.71%
PM (TTM) 5.09%
GM 26.17%
FCFM N/A
ROA(3y)3.03%
ROA(5y)2.75%
ROE(3y)8.2%
ROE(5y)7.97%
ROIC(3y)6.63%
ROIC(5y)6.34%
ROICexc(3y)10.45%
ROICexc(5y)9.43%
ROICexgc(3y)12.81%
ROICexgc(5y)11.57%
ROCE(3y)8.91%
ROCE(5y)8.53%
ROICexgc growth 3Y10.44%
ROICexgc growth 5Y8.61%
ROICexc growth 3Y11.05%
ROICexc growth 5Y7.72%
OM growth 3Y3.27%
OM growth 5Y3.94%
PM growth 3Y7.81%
PM growth 5Y7.66%
GM growth 3Y-3.21%
GM growth 5Y-2.88%
F-Score5
Asset Turnover0.74
Health
Industry RankSector Rank
Debt/Equity 0.62
Debt/FCF N/A
Debt/EBITDA 2.36
Cap/Depr 113.41%
Cap/Sales 4.68%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.82
Quick Ratio 1.34
Altman-Z 1.82
F-Score5
WACC7.12%
ROIC/WACC1.13
Cap/Depr(3y)111.56%
Cap/Depr(5y)102.51%
Cap/Sales(3y)5.01%
Cap/Sales(5y)4.97%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)24.41%
EPS 3Y23.97%
EPS 5Y19.97%
EPS Q2Q%34.09%
EPS Next Y33.33%
EPS Next 2Y17.92%
EPS Next 3Y14.83%
EPS Next 5YN/A
Revenue 1Y (TTM)9.07%
Revenue growth 3Y14.06%
Revenue growth 5Y10.34%
Sales Q2Q%21.03%
Revenue Next Year19.23%
Revenue Next 2Y11.86%
Revenue Next 3Y9.07%
Revenue Next 5YN/A
EBIT growth 1Y17.64%
EBIT growth 3Y17.79%
EBIT growth 5Y14.69%
EBIT Next Year94.24%
EBIT Next 3Y29.1%
EBIT Next 5YN/A
FCF growth 1Y-245.52%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-105.92%
OCF growth 3Y26.58%
OCF growth 5Y-3.68%

SVAS BIOSANA SPA / SVS.MI FAQ

What is the ChartMill fundamental rating of SVAS BIOSANA SPA (SVS.MI) stock?

ChartMill assigns a fundamental rating of 6 / 10 to SVS.MI.


Can you provide the valuation status for SVAS BIOSANA SPA?

ChartMill assigns a valuation rating of 7 / 10 to SVAS BIOSANA SPA (SVS.MI). This can be considered as Undervalued.


How profitable is SVAS BIOSANA SPA (SVS.MI) stock?

SVAS BIOSANA SPA (SVS.MI) has a profitability rating of 5 / 10.


What are the PE and PB ratios of SVAS BIOSANA SPA (SVS.MI) stock?

The Price/Earnings (PE) ratio for SVAS BIOSANA SPA (SVS.MI) is 6.96 and the Price/Book (PB) ratio is 0.77.


Is the dividend of SVAS BIOSANA SPA sustainable?

The dividend rating of SVAS BIOSANA SPA (SVS.MI) is 6 / 10 and the dividend payout ratio is 19.64%.